Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)
China flag China · Delayed Price · Currency is CNY
20.16
-0.08 (-0.40%)
Feb 4, 2026, 3:00 PM CST

SHA:603079 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
549.24315.62323.72320.72514.75461.31
Short-Term Investments
21.5530-1020.07110.11
Trading Asset Securities
12.020.013.01-0.01-
Cash & Short-Term Investments
582.81345.63326.74330.72534.83571.42
Cash Growth
137.13%5.78%-1.20%-38.16%-6.40%40.20%
Accounts Receivable
155.97141.24119.26135.9133.38115.02
Other Receivables
0.360.550.60.850.170.4
Receivables
156.33141.79119.86136.75133.55115.42
Inventory
194.89197.54228.48292.06222.09167.94
Other Current Assets
26.6723.8120.0720.8328.3526.36
Total Current Assets
960.69708.77695.15780.36918.81881.15
Property, Plant & Equipment
886.37769.47674.77561.81579.96576.02
Long-Term Investments
10.721.0160.760.720.7410.7
Goodwill
10.9110.9110.9110.9110.9110.91
Other Intangible Assets
224.83225.58231.82218.2156.09165.59
Long-Term Deferred Tax Assets
0.230.060.895.363.382.89
Long-Term Deferred Charges
3.16.168.674.236.8711.18
Other Long-Term Assets
49.4443.3536.2813.6468.0642.44
Total Assets
2,1461,7851,7191,6551,7651,701
Accounts Payable
172.09155.44129.61164151.33106.78
Accrued Expenses
19.7838.3133.8437.5736.0336.14
Short-Term Debt
-30.8294.7541.76167.39121.23
Current Portion of Long-Term Debt
0.480.110.14---
Current Portion of Leases
-0.80.30.590.59-
Current Income Taxes Payable
18.413.382.985.043.2120.02
Current Unearned Revenue
5.543.82.928.76.544.04
Other Current Liabilities
1.7918.7130.937.8147.470.56
Total Current Liabilities
218.09251.38295.45295.46412.5358.76
Long-Term Debt
305.5231144---
Long-Term Leases
-0.49-0.30.87-
Long-Term Unearned Revenue
7.046.655.467.586.954.69
Long-Term Deferred Tax Liabilities
3.423.714.288.437.536.44
Other Long-Term Liabilities
8.18.1---5.92
Total Liabilities
542.15501.34449.2311.78427.84375.8
Common Stock
189.03171.19171.19171.19171.19171.19
Additional Paid-In Capital
912.78669.19669.19669.19669.19669.19
Retained Earnings
495.87442.53423.26487.6480.09464.25
Treasury Stock
-22.08-22.08-8.97---
Total Common Equity
1,5761,2611,2551,3281,3201,305
Minority Interest
28.5323.1415.3115.4516.4920.43
Shareholders' Equity
1,6041,2841,2701,3431,3371,325
Total Liabilities & Equity
2,1461,7851,7191,6551,7651,701
Total Debt
305.98263.23239.242.65168.85121.23
Net Cash (Debt)
276.8382.487.54288.07365.98450.19
Net Cash Growth
6892.99%-5.86%-69.61%-21.29%-18.70%777.43%
Net Cash Per Share
1.530.480.521.652.132.67
Filing Date Shares Outstanding
187.16169.32169.32171.19171.19171.19
Total Common Shares Outstanding
187.16169.32170.46171.19171.19171.19
Working Capital
742.6457.38399.69484.9506.32522.39
Book Value Per Share
8.427.457.367.767.717.62
Tangible Book Value
1,3401,0241,0121,0991,1531,128
Tangible Book Value Per Share
7.166.055.946.426.746.59
Buildings
-290.21279.73274.11272.42271.23
Machinery
-589.14528.41515.04479.2449.64
Construction In Progress
-335.96247.3293.3388.7661.42
Source: S&P Global Market Intelligence. Standard template. Financial Sources.